Product Name

  • Name

    5-AMINO-1,3,4-OXADIAZOLE-2-CARBOXYLIC ACID ETHYL ESTER

  • EINECS
  • CAS No. 4970-53-0
  • Article Data6
  • CAS DataBase
  • Density 1.362 g/cm3
  • Solubility
  • Melting Point 199 °C
  • Formula C5H7N3O3
  • Boiling Point 289.1 °C at 760 mmHg
  • Molecular Weight 157.129
  • Flash Point 128.6 °C
  • Transport Information
  • Appearance
  • Safety 26-36
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 4970-53-0 (5-AMINO-1,3,4-OXADIAZOLE-2-CARBOXYLIC ACID ETHYL ESTER)
  • Hazard Symbols
  • Synonyms Ethyl 5-amino-1,3,4-oxadiazole-2-carboxylate;
  • PSA 91.24000
  • LogP 0.40970

Synthetic route

bromocyane
506-68-3

bromocyane

oxalic acid diethyl ester
95-92-1

oxalic acid diethyl ester

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
Stage #1: oxalic acid diethyl ester With hydrazine hydrate In ethanol at -20℃; for 0.5h;
Stage #2: bromocyane In ethanol; water at 20℃; for 1h;
31%
ethyl 2-(2-carbamoylhydrazono)acetate
999-47-3

ethyl 2-(2-carbamoylhydrazono)acetate

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: bromine; acetic acid; sodium acetate / 24 h / 20 °C
2: triethylamine / toluene / 0.17 h / 20 - 80 °C
View Scheme
Multi-step reaction with 2 steps
1: bromine; sodium acetate; acetic acid / 24 h / 20 °C
2: triethylamine / toluene / 0.17 h / 20 - 80 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium acetate; bromine / acetic acid / 24 h / 20 °C
2: triethylamine / toluene / 0.17 h / 80 °C
View Scheme
ethyl 2-bromo-2-(2-carbamoylhydrazono)acetate
13599-88-7

ethyl 2-bromo-2-(2-carbamoylhydrazono)acetate

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In toluene at 20 - 80℃; for 0.166667h;1.04 g
With triethylamine In toluene at 20 - 80℃; for 0.166667h;1.04 g
With triethylamine In toluene at 80℃; for 0.166667h;1.04 g
5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

5-amino-1,3,4-oxadiazole-2-carboxylic acid amide
4970-55-2

5-amino-1,3,4-oxadiazole-2-carboxylic acid amide

Conditions
ConditionsYield
With ammonia In methanol at 20℃; for 18h; Concentration; Temperature; Solvent; Sealed tube;99%
(1R,2R)-2-(4-bromobenzoyl)cyclohexane-1-carboxylic acid

(1R,2R)-2-(4-bromobenzoyl)cyclohexane-1-carboxylic acid

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

ethyl 5-({[(1R,2R)-2-(4-bromobenzoyl)cyclohexyl]carbonyl}amino)-1,3,4-oxadiazole-2-carboxylate

ethyl 5-({[(1R,2R)-2-(4-bromobenzoyl)cyclohexyl]carbonyl}amino)-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; triethylamine In ethyl acetate at 80℃; for 12h;98%
5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

sodium 5-amino-1,3,4-oxadiazole-2-carboxylate

sodium 5-amino-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
With water; sodium hydroxide for 1h;82%
2,4-dichloro-2-methylpyrimidine
1780-26-3

2,4-dichloro-2-methylpyrimidine

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

5-(6-chloro-2-methylpyrimidin-4-ylamino)-[1,3,4]oxadiazole-2-carboxylic acid ethyl ester

5-(6-chloro-2-methylpyrimidin-4-ylamino)-[1,3,4]oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With palladium diacetate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Catalytic behavior; Reagent/catalyst; Solvent; Temperature; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;71%
4-pentynoic acid
6089-09-4

4-pentynoic acid

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

ethyl 5-[(pent-4-ynoyl)amino]-1,3,4-oxadiazole-2-carboxylate

ethyl 5-[(pent-4-ynoyl)amino]-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 25℃; for 18h;70%
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride at 25℃; for 18h;70%
4-chloro-2-methyl-6-phenyl-pyrimidine
2915-15-3

4-chloro-2-methyl-6-phenyl-pyrimidine

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

5-(2-methyl-6-phenylpyrimidin-4-ylamino)-[1,3,4]oxadiazole-2-carboxylic acid ethyl ester

5-(2-methyl-6-phenylpyrimidin-4-ylamino)-[1,3,4]oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With palladium diacetate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;70%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

ethyl 5-[[(tert-butoxy)carbonyl]amino]-1,3,4-oxadiazole-2-carboxylate
1258411-53-8

ethyl 5-[[(tert-butoxy)carbonyl]amino]-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
With dmap; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 40℃;67%
Stage #1: 5-amino[1,3,4]oxadiazole-2-carboxylic acid ethyl ester With sodium hydride In N,N-dimethyl-formamide at 0℃; for 0.166667h;
Stage #2: di-tert-butyl dicarbonate In N,N-dimethyl-formamide at 20℃; for 16h;
56.2%
With triethylamine In N,N-dimethyl-formamide at 20℃; for 12h;55%
4-chloro-2-methyl-6-(4-nitro-phenyl)-pyrimidine

4-chloro-2-methyl-6-(4-nitro-phenyl)-pyrimidine

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

5-[2-methyl-6-(4-nitrophenyl)pyrimidin-4-ylamino][1,3,4]oxadiazole-2-carboxylic acid ethyl ester

5-[2-methyl-6-(4-nitrophenyl)pyrimidin-4-ylamino][1,3,4]oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With palladium diacetate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;66%
4-chloro-2-methyl-6-(3-nitro-phenyl)-pyrimidine

4-chloro-2-methyl-6-(3-nitro-phenyl)-pyrimidine

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

5-[2-methyl-6-(3-nitrophenyl)pyrimidin-4-ylamino][1,3,4]oxadiazole-2-carboxylic acid ethyl ester

5-[2-methyl-6-(3-nitrophenyl)pyrimidin-4-ylamino][1,3,4]oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With palladium diacetate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;61%
4-chloro-2-methyl-6-(4-methylpiperazin-1-yl)pyrimidine

4-chloro-2-methyl-6-(4-methylpiperazin-1-yl)pyrimidine

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

5-[2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-ylamino][1,3,4]oxadiazole-2-carboxylic acid ethyl ester

5-[2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-ylamino][1,3,4]oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With palladium diacetate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;55%
With xantphos; palladium diacetate; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;55%
methyl iodide
74-88-4

methyl iodide

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

ethyl 5-((bis(methylthio)methylene)amino)-1,3,4-oxadiazole-2-carboxylate

ethyl 5-((bis(methylthio)methylene)amino)-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
Stage #1: 5-amino[1,3,4]oxadiazole-2-carboxylic acid ethyl ester With sodium hydroxide In N,N-dimethyl-formamide for 0.166667h;
Stage #2: In N,N-dimethyl-formamide for 0.333333h;
Stage #3: methyl iodide In N,N-dimethyl-formamide at 0 - 20℃; for 0.5h;
37%
1-(4-(6-chloro-2-methylpyrimidin-4-yl)piperazin-1-yl)ethanone

1-(4-(6-chloro-2-methylpyrimidin-4-yl)piperazin-1-yl)ethanone

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

5-[2-methyl-6-(4-acetylpiperazin-1-yl)pyrimidin-4-ylamino][1,3,4]oxadiazole-2-carboxylic acid ethyl ester

5-[2-methyl-6-(4-acetylpiperazin-1-yl)pyrimidin-4-ylamino][1,3,4]oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With palladium diacetate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;36%
With xantphos; palladium diacetate; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;36%
2-(4-(6-chloro-2-methylpyrimidin-4-yl)piperazin-1-yl)ethanol
127116-19-2

2-(4-(6-chloro-2-methylpyrimidin-4-yl)piperazin-1-yl)ethanol

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

5-{6-[4-(2-hydroxy-ethyl)piperazin-1-yl]-2-methylpyrimidin-4-ylamino}-[1,3,4]oxadiazole-2-carboxylic acid ethyl ester

5-{6-[4-(2-hydroxy-ethyl)piperazin-1-yl]-2-methylpyrimidin-4-ylamino}-[1,3,4]oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
With palladium diacetate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;20%
With xantphos; palladium diacetate; sodium t-butanolate In N,N-dimethyl-formamide at 110℃; for 36h; Buchwald-Hartwig Coupling; Schlenk technique; Inert atmosphere;20%
4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzoic acid

4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzoic acid

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

ethyl 5-(4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzamido)-1,3,4-oxadiazole-2-carboxylate

ethyl 5-(4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzamido)-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
Stage #1: 4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzoic acid; 5-amino[1,3,4]oxadiazole-2-carboxylic acid ethyl ester With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide In dichloromethane; N,N-dimethyl-formamide at 20℃; for 1h;
Stage #2: With dmap; trimethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃;
9%
N,N-dimethylformamide diethyl diacetal
1188-33-6

N,N-dimethylformamide diethyl diacetal

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

5-(dimethylamino-methyleneamino)-[1,3,4]oxadiazole-2-carboxylic acid ethyl ester
37582-75-5

5-(dimethylamino-methyleneamino)-[1,3,4]oxadiazole-2-carboxylic acid ethyl ester

Conditions
ConditionsYield
In ethanol
5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

ethyl 5-bromo-1,3,4-oxadiazole-2-carboxylate
916889-45-7

ethyl 5-bromo-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
Stage #1: 5-amino[1,3,4]oxadiazole-2-carboxylic acid ethyl ester With copper(ll) bromide In acetonitrile at 20℃; for 0.25h;
Stage #2: With tert.-butylnitrite In acetonitrile at 20 - 50℃; for 2.5h;
ethylmagnesium bromide
925-90-6

ethylmagnesium bromide

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

3-(5-amino-1,3,4-oxadiazol-2-yl)pentan-3-ol
910656-41-6

3-(5-amino-1,3,4-oxadiazol-2-yl)pentan-3-ol

Conditions
ConditionsYield
In tetrahydrofuran at 0 - 20℃; for 0.5h; Mechanism;
cyclopropylmagnesium bromide
23719-80-4

cyclopropylmagnesium bromide

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

(5-amino-1,3,4-oxadiazol-2-yl)(dicyclopropyl)methanol

(5-amino-1,3,4-oxadiazol-2-yl)(dicyclopropyl)methanol

Conditions
ConditionsYield
Stage #1: cyclopropylmagnesium bromide; 5-amino[1,3,4]oxadiazole-2-carboxylic acid ethyl ester In tetrahydrofuran at -78 - 20℃;
Stage #2: With ammonium chloride In tetrahydrofuran; water
ethylmagnesium bromide
925-90-6

ethylmagnesium bromide

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

1-(5-amino-1,3,4-oxadiazol-2-yl)propan-1-one

1-(5-amino-1,3,4-oxadiazol-2-yl)propan-1-one

Conditions
ConditionsYield
Stage #1: ethylmagnesium bromide; 5-amino[1,3,4]oxadiazole-2-carboxylic acid ethyl ester In tetrahydrofuran at -78 - 20℃;
Stage #2: With ammonium acetate In tetrahydrofuran; water
cinchophen
132-60-5

cinchophen

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

N-(5-ethoxycarbonyl-1,3,4-oxadiazol-2-yl)-2-phenyl-4-quinolinecarboxamide
1236056-69-1

N-(5-ethoxycarbonyl-1,3,4-oxadiazol-2-yl)-2-phenyl-4-quinolinecarboxamide

Conditions
ConditionsYield
With 1-hydroxy-7-aza-benzotriazole; N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide
2-phenylquinoline-4-carbonyl chloride
59661-86-8

2-phenylquinoline-4-carbonyl chloride

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

N-(5-ethoxycarbonyl-1,3,4-oxadiazol-2-yl)-2-phenyl-4-quinolinecarboxamide
1236056-69-1

N-(5-ethoxycarbonyl-1,3,4-oxadiazol-2-yl)-2-phenyl-4-quinolinecarboxamide

Conditions
ConditionsYield
With pyridine at 20 - 60℃;
5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

Ethyl 5-({[(3S)-2-((2R)-3-cyclopentyl-2-{[formyl(hydroxy)amino]methyl}propanoyl)-3-pyrazolidinyl]carbonyl}amino)-1,3,4-oxadiazole-2-carboxylate
1398750-50-9

Ethyl 5-({[(3S)-2-((2R)-3-cyclopentyl-2-{[formyl(hydroxy)amino]methyl}propanoyl)-3-pyrazolidinyl]carbonyl}amino)-1,3,4-oxadiazole-2-carboxylate

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

1,3,4-oxadiazol-2-amine
3775-60-8

1,3,4-oxadiazol-2-amine

Conditions
ConditionsYield
With sodium hydroxide In water for 0.0833333h;0.02 g
With water; sodium hydroxide at 20℃; for 0.0833333h;0.02 g
With sodium hydroxide In water at 20℃; for 0.0833333h;0.02 g
6-(5-chloro-7-methoxy-2,3-diphenylpyrazolo[1,5-a] pyrimidin-6-yl)quinoline

6-(5-chloro-7-methoxy-2,3-diphenylpyrazolo[1,5-a] pyrimidin-6-yl)quinoline

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

ethyl 5-((7-oxo-2,3-diphenyl-6-(quinolin-6-yl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)amino)-1,3,4-oxadiazole-2-carboxylate

ethyl 5-((7-oxo-2,3-diphenyl-6-(quinolin-6-yl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)amino)-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
With palladium diacetate; caesium carbonate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;
5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

ethyl 5-((6-chloro-1H-benzo[d]imidazol-2-yl)amino)-1,3,4-oxadiazole-2-carboxylate

ethyl 5-((6-chloro-1H-benzo[d]imidazol-2-yl)amino)-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydroxide / N,N-dimethyl-formamide / 0.17 h
1.2: 0.33 h
1.3: 0.5 h / 0 - 20 °C
2.1: N,N-dimethyl-formamide / 16 h / 120 °C
View Scheme
4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzoic acid

4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzoic acid

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester
4970-53-0

5-amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester

ethyl 5-(4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzamido)-1,3,4-oxadiazole-2-carboxylate

ethyl 5-(4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzamido)-1,3,4-oxadiazole-2-carboxylate

B

ethyl 5-(4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzamido)-1,3,4-oxadiazole-2-carboxylate

ethyl 5-(4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzamido)-1,3,4-oxadiazole-2-carboxylate

Conditions
ConditionsYield
Stage #1: 4-((3,5-dimethylpiperidin-1-yl)sulfonyl)benzoic acid; 5-amino[1,3,4]oxadiazole-2-carboxylic acid ethyl ester With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide In dichloromethane; N,N-dimethyl-formamide at 20℃; for 1h; Sealed tube;
Stage #2: With dmap; triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; Sealed tube; Overall yield = 9%; Overall yield = 19 mg;
A n/a
B n/a

1,3,4-Oxadiazole-2-carboxylicacid, 5-amino-, ethyl ester Specification

The 1,3,4-Oxadiazole-2-carboxylicacid, 5-amino-, ethyl ester is the organic compound with the formula C5H7N3O3. With the CAS registry number 4970-53-0, its IUPAC name is ethyl 5-amino-1,3,4-oxadiazole-2-carboxylate. The substance should be sealed and stored in dry and well-ventilated place.

Physical properties of 1,3,4-Oxadiazole-2-carboxylicacid, 5-amino-, ethyl ester: (1)ACD/LogP: -0.15; (2)ACD/LogD (pH 5.5): -0.15; (3)ACD/LogD (pH 7.4): -0.15; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 19.86; (7)ACD/KOC (pH 7.4): 19.86; (8)#H bond acceptors: 6; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 3; (11)Index of Refraction: 1.525; (12)Molar Refractivity: 35.37 cm3; (13)Molar Volume: 115.3 cm3; (14)Surface Tension: 59.2 dyne/cm; (15)Density: 1.362 g/cm3; (16)Flash Point: 128.6 °C; (17)Enthalpy of Vaporization: 52.84 kJ/mol; (18)Boiling Point: 289.1 °C at 760 mmHg; (19)Vapour Pressure: 0.00224 mmHg at 25°C.

When you are using this chemical, please be cautious about it as the following:
It is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. Whenever you will contact it, please wear suitable protective clothing.

You can still convert the following datas into molecular structure:
(1)Canonical SMILES: CCOC(=O)C1=NN=C(O1)N
(2)InChI: InChI=1S/C5H7N3O3/c1-2-10-4(9)3-7-8-5(6)11-3/h2H2,1H3,(H2,6,8)
(3)InChIKey: JZSBFOOEPYPCPW-UHFFFAOYSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View